Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXT0YQ
|
||||
| Drug Name |
[3-(1H-Indol-3-yl)-propyl]-[2-(naphthalen-1-yloxy)-ethyl]-amine
|
||||
| Synonyms |
CHEMBL126253
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H24N2O
|
||||
| Canonical SMILES |
C(CNCCOc1cccc2ccccc12)Cc3c[nH]c4ccccc34
|
||||
| InChI |
InChI=1S/C23H24N2O/c1-2-11-21-18(7-1)8-5-13-23(21)26-16-15-24-14-6-9-19-17-25-22-12-4-3-10-20(19)22/h1-5,7-8,10-13,17,24-25H,6,9,14-16H2
|
||||
| InChIKey |
LTMYWNLLSXEOLG-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.